The DISCOVER Trial: Application of the Karius Plasma Next-Generation Sequencing Test for Pathogen Detection in Stem-Cell Transplant Patients
Monica Fung(University of California, San Francisco), Peter Chin‐Hong(University of California, San Francisco), Mickey Kertesz, Desiree Hollemon, David K. Hong(Unknown), Aaron C. Logan(University of California, San Francisco), Hon Seng, Kathy Wong(Joslin Diabetes Center), Estelle Dolan(University of California, Davis), Tim Blauwkamp, Jamie Eng(University of California, San Francisco)
Cited by 3
Related Papers
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
|Proceedings of the National Academy of Sciences|2018|434